Increased Th1 and suppressed Th2 serum cytokine levels in subjects with diabetic coronary artery disease

Cardiovascular Diabetology

Volumn 13, Issue 1, 2014, Pages

  Madhumitha, Haridoss ^a   Mohan, Viswanathan ^b   Deepa, Mohan ^b   Babu, Subash ^c   Aravindhan, Vivekanandhan ^a  

^a ANNA UNIVERSITY   (India)

^b MADRAS DIABETES RESEARCH FOUNDATION   (India)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

CAD; IFN ; IL 12; IL 13; IL 2; IL 4; IL 5; T2DM

Indexed keywords

GAMMA INTERFERON; HEMOGLOBIN A1C; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTICLE; BIOCHEMISTRY; BLOOD LEVEL; CARDIOVASCULAR RISK; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETIC CARDIOMYOPATHY; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; RECEPTOR DOWN REGULATION; TH1 CELL; TH2 CELL;

ADULT; AGED; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; CYTOKINES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INDIA; MALE; MIDDLE AGED; TH1-TH2 BALANCE; YOUNG ADULT;

EID: 84891770455     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-13-1     Document Type: Article

References (30)

1. Pickup JC, Mattock MB, Chusney GD, Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997, 40(11):1286-1292. 10.1007/s001250050822, 9389420.
2. Rizvi AA. Cytokine biomarkers, endothelial inflammation, and atherosclerosis in the metabolic syndrome: emerging concepts. Am J Med Sci 2009, 338(4):310-318. 10.1097/MAJ.0b013e3181a4158c, 19726972.
3. Chu CS, Lee KT, Cheng KH, Lee MY, Kuo HF, Lin TH, Su HM, Voon WC, Sheu SH, Lai WT. Postchallenge responses of nitrotyrosine and TNF-alpha during 75-g oral glucose tolerance test are associated with the presence of coronary artery diseases in patients with prediabetes. Cardiovasc Diabetol 2012, 11:21. 10.1186/1475-2840-11-21, 3316140, 22397368.
4. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 1986, 6(2):131-138. 10.1161/01.ATV.6.2.131, 2937395.
5. Romagnani S. Th1/Th2 cells. Inflamm Bowel Dis 1999, 5(4):285-294. 10.1097/00054725-199911000-00009, 10579123.
6. Miller AM. Role of IL-33 in inflammation and disease. J Inflamm (Lond) 2011, 8(1):22. 10.1186/1476-9255-8-22, 3175149, 21871091.
7. Surendar J, Mohan V, Rao MM, Babu S, Aravindhan V. Increased levels of both Th1 and Th2 cytokines in subjects with metabolic syndrome (CURES-103). Diabetes Technol Ther 2011, 13(4):477-482. 10.1089/dia.2010.0178, 21355722.
8. Gotsman I, Stabholz A, Planer D, Pugatsch T, Lapidus L, Novikov Y, Masrawa S, Soskolne A, Lotan C. Serum cytokine tumor necrosis factor-alpha and interleukin-6 associated with the severity of coronary artery disease: indicators of an active inflammatory burden?. Isr Med Assoc J 2008, 10(7):494-498.
9. Dinh W, Futh R, Nickl W, Krahn T, Ellinghaus P, Scheffold T, Bansemir L, Bufe A, Barroso MC, Lankisch M. Elevated plasma levels of TNF-alpha and interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders. Cardiovasc Diabetol 2009, 8:58. 10.1186/1475-2840-8-58, 2778641, 19909503.
10. Ofstad AP, Gullestad L, Orvik E, Aakhus S, Endresen K, Ueland T, Aukrust P, Fagerland MW, Birkeland KI, Johansen OE. Interleukin-6 and activin A are independently associated with cardiovascular events and mortality in type 2 diabetes: the prospective Asker and Baerum Cardiovascular Diabetes (ABCD) cohort study. Cardiovasc Diabetol 2013, 12(1):126. 10.1186/1475-2840-12-126, 3766106, 23987834.
11. Deepa M, Pradeepa R, Rema M, Mohan A, Deepa R, Shanthirani S, Mohan V. The Chennai Urban Rural Epidemiology Study (CURES)-study design and methodology (urban component) (CURES-I). J Assoc Physicians India 2003, 51:863-870.
12. Mohan V, Ravikumar R, Shanthi Rani S, Deepa R. Intimal medial thickness of the carotid artery in South Indian diabetic and non-diabetic subjects: the Chennai Urban Population Study (CUPS). Diabetologia 2000, 43(4):494-499. 10.1007/s001250051334, 10819244.
13. Ravikumar R, Deepa R, Shanthirani C, Mohan V. Comparison of carotid intima-media thickness, arterial stiffness, and brachial artery flow mediated dilatation in diabetic and nondiabetic subjects (The Chennai Urban Population Study [CUPS-9]). Am J Cardiol 2002, 90(7):702-707. 10.1016/S0002-9149(02)02593-6, 12356381.
14. Wilkinson IB, Fuchs SA, Jansen IM, Spratt JC, Murray GD, Cockcroft JR, Webb DJ. Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens 1998, 16(12 Pt 2):2079-2084.
15. Enas EA, Mehta J. Malignant coronary artery disease in young Asian Indians: thoughts on pathogenesis, prevention, and therapy. Coronary Artery Disease in Asian Indians (CADI) Study. Clin Cardiol 1995, 18(3):131-135. 10.1002/clc.4960180305, 7743682.
16. Rana JS, Nieuwdorp M, Jukema JW, Kastelein JJ. Cardiovascular metabolic syndrome - an interplay of, obesity, inflammation, diabetes and coronary heart disease. Diabetes Obes Metab 2007, 9(3):218-232. 10.1111/j.1463-1326.2006.00594.x, 17391148.
17. Frostegard J. Immune mechanisms in atherosclerosis, especially in diabetes type 2. Front Endocrinol (Lausanne) 2013, 4:162. 3810619, 24194733.
18. Rocha VZ, Folco EJ, Sukhova G, Shimizu K, Gotsman I, Vernon AH, Libby P. Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ Res 2008, 103(5):467-476. 10.1161/CIRCRESAHA.108.177105, 2740384, 18658050.
19. Pacifico L, Di Renzo L, Anania C, Osborn JF, Ippoliti F, Schiavo E, Chiesa C. Increased T-helper interferon-gamma-secreting cells in obese children. Eur J Endocrinol 2006, 154(5):691-697. 10.1530/eje.1.02138, 16645016.
20. Wegner M, Winiarska H, Bobkiewicz-Kozlowska T, Dworacka M. IL-12 serum levels in patients with type 2 diabetes treated with sulphonylureas. Cytokine 2008, 42(3):312-316. 10.1016/j.cyto.2008.02.014, 18397831.
21. Jiang LQ, Franck N, Egan B, Sjogren RJ, Katayama M, Duque-Guimaraes D, Arner P, Zierath JR, Krook A. Autocrine role of interleukin-13 on skeletal muscle glucose metabolism in Type 2 diabetic patients involves microRNA let-7. Am J Physiol Endocrinol Metab 2013, 305(11):E1359-E1366. 10.1152/ajpendo.00236.2013, 24105413.
22. Chang YH, Ho KT, Lu SH, Huang CN, Shiau MY. Regulation of glucose/lipid metabolism and insulin sensitivity by interleukin-4. Int J Obes (Lond) 2011, 36(7):993-998.
23. Jonasson L, Holm J, Skalli O, Gabbiani G, Hansson GK. Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. J Clin Invest 1985, 76(1):125-131. 10.1172/JCI111934, 423725, 3894417.
24. Frostegard J, Ulfgren AK, Nyberg P, Hedin U, Swedenborg J, Andersson U, Hansson GK. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 1999, 145(1):33-43. 10.1016/S0021-9150(99)00011-8, 10428293.
25. Gupta S, Pablo AM, Jiang X, Wang N, Tall AR, Schindler C. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J Clin Invest 1997, 99(11):2752-2761. 10.1172/JCI119465, 508122, 9169506.
26. LaFramboise WA, Dhir R, Kelly LA, Petrosko P, Krill-Burger JM, Sciulli CM, Lyons-Weiler MA, Chandran UR, Lomakin A, Masterson RV, et al. Serum protein profiles predict coronary artery disease in symptomatic patients referred for coronary angiography. BMC Med 2012, 10:157. 10.1186/1741-7015-10-157, 3566965, 23216991.
27. Mallat Z, Taleb S, Ait-Oufella H, Tedgui A. The role of adaptive T cell immunity in atherosclerosis. J Lipid Res 2009, 50(Suppl):S364-S369. 2674704, 19050311.
28. Fernandes JL, Mamoni RL, Orford JL, Garcia C, Selwyn AP, Coelho OR, Blotta MH. Increased Th1 activity in patients with coronary artery disease. Cytokine 2004, 26(3):131-137. 10.1016/j.cyto.2004.01.007, 15135807.
29. Szodoray P, Timar O, Veres K, Der H, Szomjak E, Lakos G, Aleksza M, Nakken B, Szegedi G, Soltesz P. TH1/TH2 imbalance, measured by circulating and intracytoplasmic inflammatory cytokines-immunological alterations in acute coronary syndrome and stable coronary artery disease. Scand J Immunol 2006, 64(3):336-344. 10.1111/j.1365-3083.2006.01816.x, 16918703.
30. Ishigami T, Abe K, Aoki I, Minegishi S, Ryo A, Matsunaga S, Matsuoka K, Takeda H, Sawasaki T, Umemura S, et al. Anti-interleukin-5 and multiple autoantibodies are associated with human atherosclerotic diseases and serum interleukin-5 levels. ab 2013, 27(9):3437-3445.